Review of outcomes following implementation of the NAFLD bundle
| NAFLD bundle completed n=23 | NAFLD bundle not completed n=27 | p value | |
| Consultant review (ie, not trainee) | 52% | 48% | |
| Age (years)* | 60 (22–82) | 63 (30–81) | 0.43 |
| Sex (% male) | 57% | 63% | 0.77 |
| Body Mass Index* | 33.8 (25.9–52) | 35 (29–44) | 0.69 |
| Stage 3 or 4 fibrosis | 61% | 44% | 0.27 |
| Metabolic risk factors | |||
| Obesity | 96% | 84% | 0.31 |
| Type 2 diabetes mellitus | 61% | 56% | 1.0 |
| Hypertension | 61% | 56% | 1.0 |
| Dyslipidaemia | 83% | 85% | 1.0 |
| Interventions | |||
| Target weight documented | 78% | 22% | <0.001 |
| Blood pressure reviewed | 78% | 22% | <0.001 |
| Diabetes reviewed | 100% | 44% | <0.001 |
| Dyslipidaemia reviewed | 100% | 78% | 0.016 |
| Alcohol intake documented | 87% | 41% | 0.001 |
| Patient provided with NAFLD information booklet | 96% | 11% | <0.001 |
| Dietary advice documented | 100% | 59% | 0.001 |
| Exercise advice documented | 96% | 56% | 0.001 |
*Mann-Whitney U test used.
BMI, body mass index.